The postembryonic development of the gastrointestinal tract is subject to regulation by the colonizing microbiota. This maturation process requires the commensal bacteria to cross-talk with host cells by way of recognizing receptors and inducing signaling pathways to activate transcription factors such as the nuclear receptors. Here, we show that in colonic cell lines and in primary colonic cells, Enterococcus faecalis isolated from newborn babies possess the ability to regulate peroxisome proliferator-activated receptor-␥1 (PPAR␥1) activity through phosphorylation. This results in elevated DNA binding and transcriptional activation of downstream target genes, including IL-10, a cytokine known to modulate innate immune function. Furthermore, phosphorylation appears tightly regulated as phospho-PPAR␥1 becomes an immediate substrate for degradation possibly to curtail any extended transactivation. The involvement of PPAR␥1 in a myriad of physiological processes further confirms that microflora-driven regulation might be important for a number of homeostatic strategies in the gut.
T
he peroxisome proliferator-activated receptor-␥ (PPAR␥) is a nuclear receptor involved in lipid metabolism, glucose homeostasis, inflammation, and regulation of cell specification (for a review, see ref. 1) . There are two isoforms of PPAR␥, ␥1 and ␥2, and each forms heterodimers with the retinoid X receptor (RXR), resulting in a complex that binds PPARresponsive elements (PPREs) within target gene promoters. Ligands for PPAR␥ include naturally occurring fatty acids and their derivatives, along with the synthetic antidiabetic drugs thiazolidinediones (2) .
PPAR␥ expression ranges from high levels in white and brown adipose tissue to moderate levels in macrophages, colon, kidney, and liver (3) . Although PPAR␥2 plays an important role in adipogenesis, PPAR␥1 is the dominant form in virtually all other tissues. Interestingly, ligand activation of PPAR␥1 alters cell morphology and the expression of genes consistent with a more differentiated phenotype in human colon cancer cells (4, 5) .
The main function of the gastrointestinal tract is to supply the body with nutrients and energy to sustain satisfactory metabolism. The physiological mechanism is in part tuned by the interplay between the intestinal epithelium and resident gut microflora. Exposure to the microbiota immediately after birth is an event intimately coupled to dramatic changes in nutrient intake. Thus, the resident flora become an essential component of digestion necessary for the uptake of nutrients (reviewed in ref. 6 ). Moreover, colonization by the normal microbiota has been suggested to impose a tuning of the state of physiological inflammation to mount the necessary rapid response against incoming pathogens (7) .
At least 27 nuclear receptors are expressed in the colon (8) , of which PPAR␥1 and liver receptor homolog (9) are strongly implicated in colon inflammation, whereas PPAR␥ and PPAR␦ may play opposing roles in colon cancer (reviewed in ref. 10) . Given that the colon harbors Ϸ10 9 bacterial cells per gram (11) , comprising 400 or so species, it is conceivable that our prokaryotic community has a direct impact on host protein function. This may be part of the basis for the establishment of gut homeostasis.
Our previous data indicating that PPAR␥ may participate directly in host-bacteria cross-talk, as well as the establishment of innate immune functions, made this nuclear receptor an ideal target for further mechanistic studies (12) . A number of mechanisms by which PPAR␥ could be influenced by the resident flora could be envisaged. Second messengers in the form of bacterial components, or derivatives of such, could act as ligands for a number of different nuclear receptors. Activation of nuclear receptors through the induction of cell-surface receptors such as Toll-like receptors (TLRs) may be another mechanism.
Transcription factors are powerful regulators of gene function. Aberrant expression of prolonged activity results in drastic changes of cell fate that may result in perturbed gut homeostasis. Posttranslational modification is an important form of receptor modulation that impacts on function. One of these modifications, mostly studied in human PPAR␥2, is the phosphorylation of a MAPK-dependent serine residue (Ser-114), which is reported to repress transcriptional activity of the receptor during adipocyte differentiation (13, 14) . In stark contrast, the same MAPK-dependent phosphorylation also has been shown to activate PPAR␥1-mediated transcription in other studies, implying a difference between PPAR isoforms or cell-type response to these variants (15, 16) . Interestingly, the initiation of proteasomal degradation coupled to the phosphorylation of PPAR␥ adds to the complex picture reported for receptor regulation (17, 18) .
Having established that commensal bacteria could influence PPAR␥1 activity, we set out to assess whether receptor phosphorylation could be subject to bacterial regulation in colonic epithelium. In the present study, we have used a phospho-Ser-84/114-PPAR␥-specific antibody to monitor changes in the phosphorylation status of the receptor. Our results show that a panel of Enterococci isolates from newborn babies, as well as specific ligands, induce phosphorylation of endogenous PPAR␥1 and thus increase DNA binding and target gene expression, including IL-10. Furthermore, phosphorylated PPAR␥1 rapidly becomes subject to protein degradation, a process that is restrained by proteasome inhibitors. Finally, in primary murine colonocytes, the presence of Enterococci appears to transiently retain the phosphorylated form of PPAR␥1, akin to that seen when treated with proteasomal inhibitors. The importance of bacterial modulation of phospho-PPAR␥1 offers a unique insight into one means of regulating colonic homeostasis during development.
Results

Synthetic Ligands Induce Phosphorylation of Endogenous PPAR␥1 in
HT-29. To assess the impact of ligands on the induction of PPAR␥ phosphorylation, we monitored the protein phosphorylation status in the colonic adenocarcinoma cell line HT-29. Cells were stimulated with known PPAR␥ ligands (ciglitazone, pioglitazone, rosiglitazone, and troglitazone), along with the nonsynthetic ligand, 15-deoxy prostaglandin J2 (15d-PGJ2), all resulting in the phosphorylation of PPAR␥1 (Fig. 1A) . Pioglitazone was then used for both different durations and with varying concentrations to study the effect of PPAR␥1 on phosphorylation. Concentrations as low as 50 nM yielded an altered phosphorylation pattern, and this phenomenon appeared to be PPAR␥ ligand-restricted because 100 M PPAR␣-specific ligand WY-14643 did not have the same effect (Fig. 1B) . Moreover, induced phosphorylation appeared within 30 min of stimulation, peaking at 1-2 h, without affecting the pool of total PPAR␥ (Fig. 1C) . Notably, ligand-dependent phosphorylation was confirmed through the use of a ligand-binding inhibitor, GW9662, which efficiently prevented the phosphorylation of the receptor (Fig. 1D) . performed EMSAs by using a PPAR␥-specific probe on nuclear extracts from ligand-treated HT-29 cells. Importantly, increasing the pool of phospho-PPAR␥1 protein resulted in elevated DNA binding, which in turn was prevented by the PPAR␥ antagonist, GW9662 (GWϩPio; Fig. 2A ). Furthermore, a monoclonal antibody recognizing Ser-84 phosphorylation of PPAR␥1 supershifted the majority of complex I, whereas the total PPAR␥ antibodies depleted both DNA-binding complexes (Fig. 2B) . Hence, changes seen in DNA binding would primarily represent changes due to phosphorylation of PPAR␥1. Oligonucleotide pulldown using a biotinylated DR-1 element from the CYP450 gene was used to monitor the phospho-PPAR␥ levels bound to DNA. In Fig. 2C , the levels of phosphorylated PPAR␥ binding to DNA increased in extracts from cells cocultured with rosiglitazone. EMSA also was performed on nuclear extracts from HT-29s cocultured with different isolates of Enterococcus faecalis, which are early colonizers of the human gut. All four isolates (EC1, EC3, EC15, and EC16) seemed to affect DNA binding of PPAR␥1 (Fig. 2D) . We decided to focus on one of the isolates, EC16, and established its rapid but transient effect on receptor DNA binding (data not shown). We proceeded to show that phospho-PPAR␥1 is a component of the altered DNAbinding complex in EC16-stimulated cells through supershift assay (Fig. 2E ). The same increase as with ligand stimuli in DNA binding can be seen after EC16 stimulation (Fig. 2F ). Here we also show the presence of the PPAR␥-binding partner, RXR, confirming proper DNA complex formation, along with the nonspecific DNA-binding protein, Ku70, as a loading control. Having demonstrated that resident flora from newborn children as well as synthetic ligands regulate the DNA binding of PPAR␥1 in a phosphorylationdependent manner, we next evaluated whether this phenomenon would correlate to the activation of downstream target genes by using SYBR Green-based real-time PCR. Time points of gene expression evaluation were set to 6 h to account for early transcriptional events. The effects on target gene expression were assessed, where the target gene, ADRP (or adipophilin), along with yet another PPAR␥ target gene, FIAF (or angiopoietin-like protein 4) (19, 20) , were strongly induced by EC16 as well as a PPAR␥-specific ligand, rosiglitazone (Fig. 3 A and B) . In addition to ADRP and FIAF, we analyzed the effect of EC16 in IL-10, a cytokine essential for the maintenance of gut homeostasis. Here we show that IL-10 expression by HT-29 cells is increased when cocultured with both EC16 (Fig. 3C Left) and specific ligand (Fig. 3C Right) . Furthermore, a decline in PPAR␥ protein levels, as achieved by specific siRNA knockdown experiments, indicated that EC16-induced FIAF expression is indeed dependent on PPAR␥ (Fig. 3D) . The EC16-induced FIAF expression also was reviewed when testing the influence of the three different kinase inhibitors, PD98059, LY294002, and SB203580. This shows that the induction can be inhibited by LY294002 and partially by SB203580, whereas PD98059 seems unable to influence expression (Fig. 3E) . HT-29s treated with EC16, together with either LY294002 or SBB203580, also show decreased levels of phospho-PPAR␥1 (Fig. 3F) , indicating that the PI3-kinase and, to some extent, the p38 MAPK pathways are instrumental in directing phosphorylation and, thus, activity.
Proteasomal Inhibition Sustains Phospho-PPAR␥1 Levels and Prolongs
DNA Binding of the Receptor Complex. To establish whether the pool of phospho-PPAR␥1 was influenced by degradation, HT-29 cells were subjected to the calpain inhibitor, ALLN, the 20S proteasome inhibitor, lactacystin, and a modifier of the proteasomal catalytic subunits, epoxomicin. All treatments led to the accumulation of the phosphorylated form of PPAR␥1, differing only in the longevity of degradation inhibition (Fig. 4A) . The amount of phosphorylated protein was elevated under the influence of MG-132 and even further so when costimulated with pioglitazone, which in turn could be inhibited by GW9662 (Fig. 4B) . The disappearance of the phospho-PPAR␥1-containing complex I in EMSAs at later time points (Fig. 2 A) due to transient ligand effects can be impeded by MG-132 (Fig.  4C) . PPAR␥ target gene transcription was subsequently assessed. Interestingly, the inhibition of the proteasome using MG-132 is enough to increase transcription; when costimulated with ligand, the response is synergistic. This synergism seen on ADRP expression as a result of MG-132 and ligand costimulation is effectively inhibited by GW9662, thus abrogating any ligand-specific effects (Fig. 4D) . To further verify these findings, we performed similar stimulations on primary mouse colonocytes where EC16 and MG-132 both increase levels of phospho-PPAR␥1 (Fig. 4E) .
Discussion
The colonization of the human gastrointestinal tract by microbes occurs almost immediately after birth. Here we demonstrate that a strain of E. faecalis (denoted as EC16), transferred from mother to child, can regulate and activate the transcription factor PPAR␥1 in colonic cell lines as well as mouse primary colonic epithelial cells. This study reinforces the growing notion that microbiota contribute to mechanisms of homeostasis closely connected to postnatal endocrinological processes (reviewed in ref. 21) .
The phosphorylation of PPAR␥ has been reported to exhibit both positive and negative outcomes on its transcriptional capacity (22) . Our coculture experiments with a variety of isolates of E. faecalis from newborn children show that microbes can transiently affect the phosphorylation status of endogenous PPAR␥ long enough to trigger an activation of its downstream target genes. We find that the phospho-PPAR␥-RXR complex may have an important role in the interplay between microflora and colonocytes. The phospho-PPAR␥1 protein levels and the DNA binding correlate well with target gene expression levels in HT-29 cells, as demonstrated by real-time PCR. The importance of phosphorylation for the activation of transcription factors is widely acknowledged (23, 24) . Recently, it was shown that the phosphorylation of PPAR␥1 and PPAR␥2 by cyclin-dependent kinase 9 increases their activity as part of adipocyte differentiation (25) . Although a clear role for PPAR␥ in colonic epithelia has yet to emerge, our studies have attempted to place this receptor within the context of bacterial-induced gut homeostasis. Nevertheless, other receptors, including TLRs and NODs, are also vital to the maintenance of controlled inflammation and intestinal homeostasis (26) .
PPAR␥ has been linked to a variety of physiological processes and different metabolic diseases (reviewed in ref. 27 ), and we and others have suggested a protective role of the receptor in the alimentary tract (28-30). Adachi et al. (29) convincingly showed that PPAR␥ expressed in epithelial cells is essential for protection against dextran sulfate sodium-induced colitis. We demonstrate that the PPAR␥ activation by EC16 and rosiglitazone can induce the expression of IL-10. Mice devoid of IL-10 spontaneously develop enterocolitis, which can be somewhat ameliorated through the use of rosiglitazone (31) , suggesting a protective cross-talk between these two pathways. In our study, IL-10 mRNA induction by EC16 was evident already after 6 h, indicating this cytokine to be an important component in the postnatal regulation of inflammation. Selective species of E. faecalis have been shown to antagonize diarrhea induced by E. coli K88 through unknown mechanisms (32), but it is conceivable that not all strains of E. faecalis will have beneficial effects. Moreover, it was recently shown that the intestinal ecosystem is altered in cases of inflammatory reaction to stimuli in the host (33) . Importantly, the composition of the microbiota is restored after dissipation of the inflammatory signal, a feature of a healthy homeostatic mechanism. Information as to how this reconstitution is organized may be gleaned from studies such as this one.
Nevertheless, detailed mechanisms of bacteria-driven PPAR␥ activation are still poorly understood. We have extended the observations for PPAR␥ by showing the effects of Ser-84 phosphorylation of endogenous PPAR␥1 on transactivation and not only as a means for the ensuing degradation. Hence, increases in phosphorylation and subsequent degradation can both be regulated by bacterial presence. One possible set of mediators may be bacterial by-products. An earlier study provided evidence for the importance of PPAR␥ in directing the antiinflammatory activities of conjugated linoleic acid (CLA) (34) . Because CLA is a microbial by-product, this finding was suggestive of a link between luminal bacteria and PPAR␥ function.
The input from gut flora is considerable given their role in influencing our postnatal development and quality of life. PPAR␥ has been shown to regulate metabolic target genes (35) , including ADRP and FIAF, the levels of which increase in response to ligand and EC16. At present, we need to evaluate the components of this pathway, such as RXR, in mediating the response. Interestingly, both of these gene products modulate lipid accumulation in cells, a trait that has been linked to PPAR␥-driven immunomodulation in dendritic cells (36) . Moreover, IL-10 production in intestinal epithelial cells is partly dependent on the ligation of CD1d, a nonclassical MHC molecule that presents lipid antigens (37) . PPAR␥ controls the expression of CD1d in dendritic cells (38) , a function not yet determined in intestinal epithelial cells. These findings provide preliminary data linking lipid metabolism to the control of inflammation in epithelial cells. However, more experiments are required to demonstrate the molecular basis of this link.
The expression of these lipid metabolic factors also may be an important early postweaning mechanism to deal with a change in the nutritional milieu. It is therefore tempting to speculate that intestinal PPAR␥1 may be one of several transcription factors controlling lipid metabolism, under the influence of microflora, recently reported in studies of obese patients (39) . In an extended study, experiments in germ-free mouse models pointed toward a transmissible nature of obesity mediated by the microbiota (40) . Hence, it is likely that the floral composition can alter metabolic potential through host-signaling pathways such as nuclear receptors.
Given that pathogenic bacteria have various means to subvert host cell responses (41, 42) , it is conceivable that commensals and nonpathogenic microflora may possess mechanisms to regain homeostatic balance. It follows that if small changes of the functional status of microbiota could regulate potent factors such as nuclear receptors, one might envisage a targeted way of improving colonic ailments. Finally, the modulatory role of the gut microflora in both health and disease settings may open for new experimental designs to further our understanding of nuclear receptor activity in intestinal homeostasis.
Experimental Procedures
Cell Culture and Reagents. The human colorectal adenocarcinoma cell line HT-29 (HTB-38; American Type Culture Collection) was grown and maintained according to the supplier's recommendations. Colons from male 10-week-old NMRI mice were scraped for epithelial cells and cultured in DMEM (Gibco).
All agonists and antagonists were dissolved in DMSO. Pioglitazone (5 M), rosiglitazone (5 M), troglitazone (5 M), ciglitazone (5 M), 15d-PGJ2 (10 M), and GW-9662 (10 M) were all acquired from Cayman Chemical. Cells were always pretreated with GW9662 for 1 h before further stimulation to avoid competition between compounds. The proteasome inhibitors MG-132 (10 M), ALLN (25 M), epoxomicin (100 nM), and lactacystin (5 M) were all purchased from Calbiochem. The kinase inhibitors PD98059 (25 M) and LY294002 (10 M) were purchased from Calbiochem, while SB203580 (10 M) came from SigmaAldrich. The PPAR␣ ligand, WY-14643 (100 M), was procured from Biomol. Antibodies for RXR␣ (sc-553), PPAR␥ (sc-7273 and sc-7196), and Actin (sc-1616) were obtained from Santa Cruz Biotechnology, and the anti-phospho-PPAR␥-specific antibody, MAB-3632, was purchased from Chemicon.
The E. faecalis used here were isolates obtained from 1-month-old (EC1) and 3-day-old (EC3, EC15, and EC16) infants. Isolates were always added to cells at a concentration of 10 6 .
EMSA. DNA binding was assayed by using 5 g of nuclear extracts in binding buffer consisting of 25 mM Hepes (pH 7.9), 70 mM KCl, 10% glycerol, 5 mM DTT, and 1 g of polydIdC (Amersham) in the presence of 50,000 cpm of a radiolabeled oligonucleotide probe. The probe chosen was an element of high PPAR␥-specificity and moderate affinity to ensure low involvement of additional PPARs (43) . The element used was the ARE6 DR1 site of the mouse adipocyte lipid-binding protein, aP2, of the following sequence: 5Ј-TCTCTCTGGGTGAAATGTGC-3Ј, 5Ј-AGAGGCACATTTCACCCAGAGAGA-3Ј. Supershift assays were carried out by initial incubation of the extracts in binding buffer, together with 500 ng of the antibody of interest, as well as suitable controls, for 25 min at room temperature. Thereafter, polydIdC and probe were added to extracts and incubated for 30 min before gel electrophoresis.
Oligonucleotide Pulldown Assay. To trap DNA-binding complexes for further investigation, we used an oligonucleotide pulldown assay. Custom biotinylated oligonucleotides of a high-affinity PPRE in the CYP4A6/P450 IV family [CYP4A6(Z)] were designed: 5Ј-Biotin-CTGAACTAGGGCAAAGTTCACAGT-3Ј, 5Ј-biotin-ACTGTGAACTTTGCCCTAGTTCAG-3Ј. These were coupled (1 g per sample) to streptavidin-coated Sepharose beads (Amersham Biosciences) and used to pull down DNA-binding PPAR␥-RXR heterodimers from 80 g of nuclear extracts in a binding buffer consisting of 12% glycerol, 12 mM Hepes (pH 7.9), 4 mM Tris (pH 7.9), 150 mM KCl, 1 mM EDTA, 1 mM DTT, 10 g poly (dIdC)/300 g protein, 1.2 mM PMSF, and 1x Complete (Roche).
Real-Time PCR. Total RNA was extracted by using an RNeasy mini-kit (Qiagen), and cDNA synthesis was performed by using SuperScript II (Invitrogen), both according to the manufacturer's instructions. We have designed and tested a selection of annotated and potential target genes for PPAR␥ by using SYBR Green (Applied Biosystems)-based semiquantitative real-time PCR. Primers were designed and tested according to Applied Biosystems recommendations: ADRP forward, 5Ј-CTGTTCACCTGATTGAATTTGC-3Ј, reverse, 5Ј-AGAGCT-TATCCTGAGCATCCTG-3Ј; ␤-actin forward, 5Ј-CCTGGCACCCAGCACAAT-3Ј, reverse, 5Ј-gccgatccacacggagtact-3Ј; FIAF forward, 5Ј-AAAGAGGCTGC-CCGAGAT-3Ј, reverse, 5Ј-TCTCCCCAACCTGGAACA-3Ј; IL-10 forward, 5Ј-TCCCTGTGAAAACAAGAGCA-3; reverse, 5-TGTCAAACTCACTCATGGCTTT-3Ј. The sample setups always included biological duplicates and experimental triplicates. Data are presented as fold change in the relative gene expression.
RNA Interference. The siRNA for PPAR␥ and scrambled control was purchased from Dharmacon, along with the transfection reagent suitable for the HT-29 cell line (Dharmafect 4). Transfection efficiency was always confirmed through either Western blot or real-time PCR and was carried out at least 24 h before any further stimulation of cells.
Western Blot Analysis. Cells treated according to figure specifications were harvested and lysed. Nuclear extracts were prepared according the nuclear extracts protocol of Schreiber (44), whereas whole-cell extracts were made with Schindler lysis buffer [50 mM Tris (pH 8), 0.1 mM EDTA, 0.5% Nonidet P-40, 10% glycerol, and 150 mM NaCl]. To prevent dephosphorylation in prepared extracts, 10 nM okadaic acid, 5 mM sodium fluoride, and 400 M sodium vanadate were added, along with 1ϫ Complete (Roche) and 1 mM PMSF. Immunodetection with an appropriate secondary peroxidaseconjugated antibody (DAKO) was followed by chemiluminescence (ECL; Amersham). Western blots were always sequentially probed with phospho-PPAR␥, total PPAR␥.
Quantification of protein bands was performed by using the Quantity One analysis software of the Discovery Series (Bio-Rad).
